Evommune, Inc. (EVMN) stock
EVMNNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$7.10−0.53 (-6.95%)
Close on Nov 16, 2026Market cap $257.67MP/E –Yield –
Evommune enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Evommune's enterprise value was $111.96M on Nov 11, 2026, against -$43.86M a year earlier.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $111.96M | – |
| 2025 | Dec 31, 2025 | -$49.44M | – |
See a number that looks wrong?